IBIO – ibio, inc. (US:NASDAQ)

News

iBio to Participate in Upcoming Investor Conferences
iBio (NYSE:IBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $5.00 price target on the stock.
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
iBio Announces $26 Million Private Placement
iBio (NASDAQ:IBIO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com